At ASH, Lilly makes case to widen Jaypirca use in leukemia, lymphoma
At ASH, Lilly makes case to widen Jaypirca use in leukemia, lymphoma
At ASH, Lilly makes case to widen Jaypirca use in leukemia, lymphoma
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.